Mucoepidermoid carcinoma of the parotid gland: Factors affecting outcome

Head and Neck

Volumn 33, Issue 4, 2011, Pages 497-503

  Ghosh Laskar, Sarbani ^a   Murthy, Vedang ^a   Wadasadawala, Tabassum ^a   Agarwal, Jaiprakash ^a   Budrukkar, Ashwini ^a   Patil, Nikhilesh ^a   Kane, Shubhada ^a   Chaukar, Devendra ^a   Pai, Prathamesh ^a   Chaturvedi, Pankaj ^a   D'Cruz, Anil ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

carcinoma; mucoepidermoid; outcome; parotid gland; prognostic factors

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NECK TUMOR; PAROTID GLAND CARCINOMA; PAROTIDECTOMY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CARCINOMA, MUCOEPIDERMOID; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAROTID NEOPLASMS; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 79952970651     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21477     Document Type: Article

References (22)

1. Spitz MR, Batsakis JG,. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol 1984; 110: 45-49. (Pubitemid 14219684)
2. Spiro RH, Huvos AG, Berk R, Strong EW,. Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg 1978; 136: 461-468. (Pubitemid 9027654)
3. Bhattacharyya N, Fried MP,. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol 2005; 26: 39-44. (Pubitemid 40038074)
4. Stewart FW, Foote FW, Becker WF,. Muco-epidermoid tumors of salivary glands. Ann Surg 1945; 122: 820-844.
5. Brandwein MS, Ivanov K, Wallace DI, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001; 25: 835-845. (Pubitemid 32594976)
6. Evans HL,. Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading. Am J Clin Pathol 1984; 81: 696-701. (Pubitemid 14076656)
7. Batsakis JG, Luna MA,. Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol 1990; 99 (10 Pt 1): 835-838. (Pubitemid 20350206)
8. Goode RK, Auclair PL, Ellis GL,. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998; 82: 1217-1224. (Pubitemid 28155381)
9. Auclair PL, Goode RK, Ellis GL,. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer 1992; 69: 2021-2030.
10. Boahene DK, Olsen KD, Lewis JE, Pinheiro AD, Pankratz VS, Baqniewski SM,. Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience. Arch Otolaryngol Head Neck Surg 2004; 130: 849-856. (Pubitemid 38915972)
11. Kokemueller H, Brueggemann N, Swennen G, Eckardt A,. Mucoepidermoid carcinoma of the salivary glands-clinical review of 42 cases. Oral Oncol 2005; 41: 3-10. (Pubitemid 39647113)
12. Emerick KS, Fabian RL, Deschler DG,. Clinical presentation, management, and outcome of high-grade mucoepidermoid carcinoma of the parotid gland. Otolaryngol Head Neck Surg 2007; 136: 783-787. (Pubitemid 46660233)
13. Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 1992; 69: 615-619.
14. Régis De Brito Santos I, Kowalski LP, Cavalcante De Araujo V, Flávia Loqullo A, Magrin J,. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg 2001; 127: 56-60. (Pubitemid 32063987)
15. King JJ, Fletcher GH,. Malignant tumors of the major salivary glands. Radiology 1971; 100: 381-384.
16. Hosokawa Y, Shirato H, Kagei K, et al. Role of radiotherapy for mucoepidermoid carcinoma of salivary gland. Oral Oncol 1999; 35: 105-111. (Pubitemid 28546852)
17. North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME,. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1990; 18: 1319-1326. (Pubitemid 20234142)
18. Garden AS, El-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ,. Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 1997; 37: 79-85. (Pubitemid 27090137)
19. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY,. Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg 1990; 116: 290-293. (Pubitemid 20100601)
20. Terhaard CH, Lubsen H, Rasch CR, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 2005; 61: 103-111. (Pubitemid 40039111)
21. Yaparpalvi R, Fontenla DP, Tyerech SK, Boselli LR, Beitler JJ,. Parotid gland tumors: a comparison of postoperative radiotherapy techniques using three dimensional (3D) dose distributions and dose-volume histograms (DVHS). Int J Radiat Oncol Biol Phys 1998; 40: 43-49. (Pubitemid 28027565)
22. Nutting CM, Rowbottom CG, Cosgrove VP, et al. Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques. Radiother Oncol 2001; 60: 163-172. (Pubitemid 32601969)